Contents
pdf Download PDF
pdf Download XML
358 Views
1 Downloads
Share this article
Research Article | Volume: 28 Issue 1 (Jan-Dec, 2023) | Pages 1 - 3
Transcatheter Aortic Valve Replacement (TAVR): Expanding Indications to Low-Risk Patients
 ,
 ,
Under a Creative Commons license
Open Access
Published
Dec. 31, 2023
Abstract

Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of aortic stenosis, offering a less invasive alternative to surgical aortic valve replacement (SAVR). Initially reserved for high-risk and inoperable patients, TAVR has seen a rapid expansion in indications, including intermediate-risk and now low-risk populations. Recent clinical trials demonstrate the safety and efficacy of TAVR in low-risk patients, leading to shifts in clinical guidelines. This review explores the evolution of TAVR indications, focusing on its application in low-risk patients, clinical outcomes, and future directions.

Keywords
Recommended Articles
Research Article
Study of Thyroid Dysfunction among Hiv Infected Patients on Highly Active Anti-Retroviral Therapy (Haart): A Cross-Sectional Study
Published: 30/01/2025
Research Article
The Use of 3D Echocardiography in Complex Congenital Heart Disease
Published: 25/10/2022
Research Article
Plasma Adiponectin and Its Role In Coronary Artery Disease: Review Article
...
Published: 25/10/2020
Research Article
Clinical Study of Factors Influencing the Outcome of Typhoid Ileal Perforation
...
Published: 25/10/2020
© Copyright Dialogues in Cardiovascular Medicine